Skip to main content

216 publications

Name Date Type Actions

Vétoquinol to acquire the animal health business of Bioniche Life Sciences Inc.

LURE, FRANCE and BELLEVILLE, ONTARIO, CANADA, February 27, 2014 - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche’s Animal Health business for the cash purchase price of CAD$61 million.

27/02/2014 Public releases

Vétoquinol to market and distribute Vetprofen in the United States

28/11/2007 Public releases

Vetoquinol wins the Animal Pharm’s award for best European company 2020

February 8th, 2021 (Lure, France) - Vetoquinol announced today it has been awarded “Best European Company 2020” by Animal Pharm.

08/02/2021 Public releases

VETOQUINOL, SNGTV and FARMVETSYSTEMS sign a partnership agreement to offer a common, innovative digital solution to the veterinary healthcare market. September 28th, 2020 (Paris, France) VETOQUINOL, FARMVET SYSTEMS and SNGTV have signed a partnership agreement aimed at offering a common solution highlighting the complementarity of their two software, VetIMPRESS and Vetélevage to farm vets. Aware of their shared philosophy aimed at optimizing vets actions thanks to new digital technologies, they are pooling these two software programs to strengthen the role of farm vets in animal health and welfare.

28/09/2020 Public releases

Vétoquinol: 2008 results expected to be in line with objectives

At its meeting of 25 August 2008, the Board of Directors of Vétoquinol S.A. reviewed the Group’s operations and approved the financial statements for
the first half of 2008.

27/08/2008 Public releases

Vétoquinol: H1 2009 interim earnings

1.‘Hybrid’ growth
<br>2.Stronginterimresults
<br>3.Focus on twostrategicpillars:
<br>- Innovation throughR&D
<br>- Potentialfor externalgrowth
<br>4.Questions and answers

31/08/2010 Half Year Report